NGENLA is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone (GH). NGENLA is a long-acting GH with once-weekly dosing and may deliver a preferred treatment experience vs daily Genotropin. NGENLA is available with Pfizer-funded patient support and has a comparable cost to other daily GH options.1,2,3
Once-weekly dosing with NGENLA is achieved with C-Terminal Peptide (CTP) technology, extending the half-life of human Growth Hormone (hGH).
Somatrogon is composed of a human Growth Hormone molecule fused with C-terminal peptide (CTP) from naturally occurring human chorionic gonadotropin (hCG).1,5
• C-terminal peptides are naturally occurring peptides derived from the beta chain of hCG.5
• C-terminal peptides provide hCG with required longevity, but do not impact interaction with hCG and its receptor.5
• Like hGH, somatrogon binds to the GH receptor and initiates a cascade leading to changes in growth and metabolism.1
Access practical support for initiating patients on NGENLA and learn more about patient preference for weekly dosing.
Access data on the efficacy and safety profile of NGENLA.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?